XML 80 R43.htm IDEA: XBRL DOCUMENT v3.21.2
Equity-based compensation (Tables)
6 Months Ended 12 Months Ended
Jul. 03, 2021
Dec. 31, 2020
Schedule of Nonvested Restricted Stock Units Activity summary of the RSU award activity for the six months ended July 3, 2021 is as follows (number of units in thousands):
    
Number of units
    
Weighted-
average grant-
date fair value
per unit
 
Outstanding at December 31, 2020
          $  
Granted
     945        14.38  
    
 
 
          
Outstanding at April 3, 2021
     945        14.38  
Granted
     2        14.90  
Forfeited/canceled
     (4      13.53  
    
 
 
          
Outstanding at July 3, 2021
     943      $ 14.38  
    
 
 
          
 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions A summary of the Company’s assumptions used in determining the fair value of the stock options granted during the six months ended July 3, 2021 is shown in the following table.
Risk-free interest rate
   
0.59% - 1.19%
 
Expected dividend yield
    —%  
Expected stock price volatility
   
33.1% - 33.5%
 
Expected life of stock options
   
5.75
 - 
6.25
 
Weighted-average fair value of stock options granted
    $4.21 - 5.29  
 
Schedule of Stock Options Roll Forward A summary of stock option activity is as follows for the six months ended July 3, 2021 (number of options in thousands):
    
Number of
options
    
Weighted-
average exercise
price
    
Weighted
average
remaining
contractual term
 
Outstanding at December 31, 2020
          $           
Granted
     4,621        13.03           
    
 
 
                   
Outstanding at April 3, 2021
     4,621        13.03           
Granted
     4        14.90           
    
 
 
                   
Outstanding at July 3, 2021
     4,625        13.03        3.3 years  
    
 
 
                   
 
Bio Ventus LLC [Member]    
Summary of Phantom Plan Award activity  
A summary of the award activity of the Phantom Plan for the year ended December 31, 2020 is as follows (number of awards in thousands):
 
   
2012 Phantom Units
   
2015 Phantom Units
 
(awards in thousands)
 
Number of awards
   
Weighted average
grant-date fair value
   
Number of awards
   
Weighted average
grant-date fair value
 
Outstanding at December 31, 2019
    658   $ 5.72     1,139   $ 10.24
Granted
    —     $ —       553   $ 10.29
Converted to cash
    —     $ —       (146   $ 6.45
Forfeited
    —     $ —       (124   $ 12.98
 
 
 
     
 
 
   
Outstanding at December 31, 2020
    658   $ 5.72     1,422   $ 10.41
 
 
 
     
 
 
   
Awards vested at December 31, 2020
    658   $ 5.72     495   $ 8.15
 
 
 
     
 
 
   
Bio Ventus LLC [Member] | Other Phantom Unit [Member]    
Summary of Phantom Plan Award activity  
 
    
2012 Phantom Units
    
2015 Phantom Units
 
(awards in thousands)
  
Number of awards
    
Weighted average
grant-date fair value
    
Number of awards
    
Weighted average
grant-date fair value
 
Nonvested at December 31, 2019
     2    $ 10.01      667    $ 12.71
Vested during 2020
     2    $ 10.01      147    $ 10.81
Nonvested at December 31, 2020
     —      $ —        927    $ 11.62